

Celrixafor 24mg Injection (Plerixafor)
Manufactured By
Celon
Pack Of
1
Salt Composition
Plerixafor
Storage
Below 30°C
ALL SUBSTITUTES
Overview
Celrixafor 24mg Injection contains plerixafor, a stem-cell mobilization medicine used before autologous stem-cell collection. It is not chemotherapy and does not directly treat the underlying cancer. Plerixafor 24mg Injection works by blocking the CXCR4 receptor, releasing CD34+ hematopoietic stem cells from the bone marrow into circulating blood so they can be collected by apheresis. It is used with granulocyte colony-stimulating factor (G-CSF) in selected patients with multiple myeloma or non-Hodgkin lymphoma. However, the timing of plerixafor, G-CSF, and apheresis is important for successful stem-cell collection.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | Celrixafor |
| Molecule / Combination | Plerixafor |
| Strength / Composition | 24 mg |
| Dosage form | Subcutaneous injection |
| Manufacturer / Marketer | Celon |
| Pack / Presentation | 1 vial |
| Storage | Below 30°C |
| Prescription | Required |
Uses and Indications
Uses of Plerixafor 24mg Injection include the following:
- Multiple myeloma: For mobilizing stem cells before collecting stem cells autologously.
- Non-Hodgkin lymphoma: For mobilizing stem cells to increase their number for autologous transplant.
Plerixafor 24mg injection works in combination with G-CSF to induce movement of hematopoietic stem cells from the bone marrow to peripheral blood, where they can be harvested via apheresis. It can be a planned course of treatment for patients expected to have difficulty with mobilizing enough stem cells; otherwise, it can be administered if stem cell mobilization does not work well during the first attempt. Plerixafor Injection is not used for stem cell mobilization in cases of leukemia since it can also mobilize malignant cells.
How Celrixafor 24mg Injection Works
Celrixafor 24mg Injection is able to reversibly inhibit the action of the CXCR4-CXCL12 signalling system that plays an important role in retaining CD34+ stem cells within the bone marrow niche. Inhibition of the retention process leads to migration of more stem cells to the bloodstream.
Clinical Evidence for Celrixafor 24mg Injection
Phase III NHL mobilization study: Plerixafor plus G-CSF increased successful target CD34+ cell collection compared with G-CSF alone.
Phase III multiple-myeloma study: The combination significantly improved stem-cell mobilization and collection in the studied population.
Side Effects of Celrixafor 24mg Injection
Just like any other medication, Celrixafor 24mg is also associated with some side effects. Most of the side effects are minor and usually go away within some time.
Common side effects
- Diarrhoea
- Nausea
- Injection-site reactions
- Fatigue
- Headache
Dizziness
Serious side effects
- Anaphylaxis/severe hypersensitivity
- Splenic enlargement or rupture
- Leukocytosis
- Potential tumor-cell mobilization in leukemia
Critical Safety Warning
TRANSPLANT-TIMING WARNING: plerixafor 24mg must be coordinated precisely with G-CSF and apheresis. Severe left-upper abdominal or shoulder-tip pain requires urgent assessment because splenic rupture, though rare, has been reported.
Celrixafor 24mg Injection Dosage and How To Take It
Clinical context | Typical labelled / protocol guidance |
Usual adult dose | 0.24 mg/kg, given under the skin once daily before apheresis, as directed by the transplant team. |
Renal impairment | If kidney function is reduced and CrCl is 50 mL/min or less, the dose is commonly reduced to 0.16 mg/kg. |
Combination | Celrixafor 24mg Injection is given after G-CSF has been used to mobilise stem cells. The transplant team decides the exact timing. |
Maximum dose | The daily dose should not exceed the maximum amount allowed in the current medicine label. |
Important: This is just a general guideline for your understanding. Your healthcare professional will determine the correct dose and frequency and combination with G-CSF and make changes according to your kidney functions, responses, and side effects.
Celrixafor 24mg Injection Missed Dose
If you miss a Celrixafor Injection dose, it will impact the schedule of stem cell harvesting. Please call the transplant team right away; however, you must not take any other dose of the medication yourself.
Safety Advice for Celrixafor 24mg Injection
| Category | Status | Guidance |
|---|---|---|
| Pregnancy | Avoid | Inform the doctor if pregnant or planning pregnancy before receiving Celrixafor 24mg Injection as this may affect the health of unborn baby. |
| Kidney | Dose adjustment | The doctor should check kidney function and adjust the dose of Plerixafor 24mg Injection if needed. |
| Spleen | Urgent review | Report severe pain in the upper-left abdomen or left shoulder immediately to ensure safe and effective treatment. |
| Driving | Caution | Plerixafor 24mg may cause dizziness, so, avoid driving or operating machinery during the treatment. |
Monitoring During Celrixafor 24mg Injection Treatment
- Blood levels of CD34+ stem cells will be monitored, and if there is no appropriate rise, the treatment plan will be modified accordingly.
- CBC will be done for monitoring red blood cells, white blood cells, and platelets.
- The function of the kidneys will be tested using blood tests, and your treatment will be assessed in case of any changes.
- Pain or feeling of being full in the upper left abdomen or unexpected pain in the left shoulder must be brought to your doctor’s notice right away.
- Skin rash, itching, swelling, shortness of breath, dizziness, or unexpected weakness can mean an allergic reaction.
Celrixafor 24mg Injection Fact Box
| Parameter | Verified / publication wording |
|---|---|
| Brand | Celrixafor |
| Generic / Combination | Plerixafor |
| Strength | 24 mg |
| Form | Subcutaneous injection |
| Manufacturer / Marketer | Celon |
| Pack | 1 vial |
| Storage | Below 30°C |
| Major safety theme | TRANSPLANT-TIMING WARNING |
| Prescription | Yes |
Celrixafor 24mg Injection Drug Interactions
| Drug / Class | Risk | What To Do |
|---|---|---|
| G-CSF | Intentional combination | Follow the mobilization schedule exactly as advised. |
| Other mobilization regimens | Schedule-dependent | Use only the regimen planned by the transplant team. |
| Renally cleared medicines | May compound renal concerns | Review overall renal function and medication list. |
FAQs About Celrixafor 24mg Injection
Does Celrixafor 24mg Injection treat cancer?
No, Celrixafor 24mg Injection is not used to treat cancer itself. It is used to mobilize and harvest stem cells from blood for autologous stem cell transplantation. These harvested stem cells can then be used as part of the treatment for cancer or other blood disorders.
Why give G-CSF too while using Plerixafor Injection?
G-CSF is administered with Plerixafor 24mg injection since the combination promotes the transfer of more stem cells from the bone marrow into the bloodstream, making it easy to collect enough stem cells for autologous stem cell transplantation.
Why is timing important?
The timing of when you take the medicine is important since the level of stem cells should be high just before the apheresis process. However, the correct timing ensures that you have adequate stem cells in your blood.
Does kidney disease change the dose of Celrixafor 24mg Injection?
Yes. In case of decreased kidney function, an adjustment in the dose of Celrixafor 24mg injection may be necessary since the drug is excreted via the kidneys. The physician will assess kidney function and give the proper dosage according to the degree of dysfunction.
Can Plerixafor 24mg Injection be used in leukemia?
Normally, Plerixafor 24mg is not prescribed for stem cell mobilization in patients with leukemia. The drug can also cause the mobilization of cancerous blood cells, along with the normal stem cells. Thus, the decision on the use of the drug should be taken on a case-to-case basis by the doctor.
How is Celrixafor 24mg Injection given to the patient?
Celrixafor 24mg Injection is taken subcutaneously, and the common site for the administration of this drug is the abdomen. Hence, this drug is usually prescribed or recommended by the doctor itself.
What symptoms are urgent during the treatment?
Severe allergic responses, such as shortness of breath, swelling, or even loss of strength, demand immediate medical care. Any kind of pain or fullness in the upper left part of the abdomen or any sort of pain in the left shoulder while taking Celrixafor 24 mg should be immediately reported to the doctor
References
- Current Mozobil (plerixafor) prescribing information https://products.sanofi.us/mozobil/mozobil.html
- DiPersio JF, et al. Pivotal plerixafor mobilisation studies in NHL and multiple myeloma. https://digitalcommons.wustl.edu/cgi/viewcontent.cgi?article=8880&context=open_access_pubs
- DiPersio, J. F., Uy, G. L., Yasothan, U., & Kirkpatrick, P. (2009). Plerixafor. Nature reviews Drug discovery, 8(2), 105-107. https://www.nature.com/articles/nrd2819
- Fricker, S. P. (2013). Physiology and pharmacology of plerixafor. Transfusion Medicine and Hemotherapy, 40(4), 237-245. https://karger.com/tmh/article-abstract/40/4/237/304669/Physiology-and-Pharmacology-of-Plerixafor?redirectedFrom=fulltext
- Uy, G. L., Rettig, M. P., & Cashen, A. F. (2008). Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert opinion on biological therapy, 8(11), 1797-1804. https://www.tandfonline.com/doi/abs/10.1517/14712598.8.11.1797
Marketer Details
Celon
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.







